Mattei, P.; Gal, J.; Chamorey, E.; Dassonville, O.; Poissonnet, G.; Aloi, D.; Barret, M.; Safta, I.; Saada, E.; Sudaka, A.;
et al. Docetaxel-Cisplatin-Fluorouracil Induction Chemotherapy for Larynx Preservation in Patients with Locally Advanced Hypopharyngeal Cancer: Predictive Factors of Oncologic and Functional Outcomes. J. Clin. Med. 2023, 12, 1131.
https://doi.org/10.3390/jcm12031131
AMA Style
Mattei P, Gal J, Chamorey E, Dassonville O, Poissonnet G, Aloi D, Barret M, Safta I, Saada E, Sudaka A,
et al. Docetaxel-Cisplatin-Fluorouracil Induction Chemotherapy for Larynx Preservation in Patients with Locally Advanced Hypopharyngeal Cancer: Predictive Factors of Oncologic and Functional Outcomes. Journal of Clinical Medicine. 2023; 12(3):1131.
https://doi.org/10.3390/jcm12031131
Chicago/Turabian Style
Mattei, Pierre, Jocelyn Gal, Emmanuel Chamorey, Olivier Dassonville, Gilles Poissonnet, Déborah Aloi, Médéric Barret, Inga Safta, Esma Saada, Anne Sudaka,
and et al. 2023. "Docetaxel-Cisplatin-Fluorouracil Induction Chemotherapy for Larynx Preservation in Patients with Locally Advanced Hypopharyngeal Cancer: Predictive Factors of Oncologic and Functional Outcomes" Journal of Clinical Medicine 12, no. 3: 1131.
https://doi.org/10.3390/jcm12031131
APA Style
Mattei, P., Gal, J., Chamorey, E., Dassonville, O., Poissonnet, G., Aloi, D., Barret, M., Safta, I., Saada, E., Sudaka, A., Culié, D., & Bozec, A.
(2023). Docetaxel-Cisplatin-Fluorouracil Induction Chemotherapy for Larynx Preservation in Patients with Locally Advanced Hypopharyngeal Cancer: Predictive Factors of Oncologic and Functional Outcomes. Journal of Clinical Medicine, 12(3), 1131.
https://doi.org/10.3390/jcm12031131
